1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Swapna, G.V.T. Ciccosanti, C.L. Belote, R. Hamilton, K. Acton, T. Huang, Y. Xiao, R. Everett, J. Montelione, G.T. Northeast Structural Genomics Consortium (NESG) http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking To be Published 0353 NMR solution structure of Lamin-B1 protein from Homo sapiens: Northeast Structural Genomics Consortium target, HR5546A (439-549) 10.2210/pdb2kpw/pdb pdb_00002kpw 13672.312 Lamin-B1 sequence database residues 439-549 1 man polymer no no MGHHHHHHSHMTGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTA SPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTT MGHHHHHHSHMTGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTA SPPTDLIWKNQNSWGTGEDVKVILKNSQGEEVAQRSTVFKTT A HR5546A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human sample LMN2, LMNB, LMNB1 9606 Homo sapiens 469008 Escherichia coli BL21(DE3)+Magic pET 14-15C Vector Northeast Structural Genomics Consortium NESG PSI, Protein Structure Initiative pdbx_database_status pdbx_nmr_representative pdbx_nmr_sample_details pdbx_nmr_software pdbx_nmr_spectrometer pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif database_2 pdbx_nmr_exptl_sample pdbx_nmr_sample_details struct pdbx_database_status repository Initial release Version format compliance Data collection Database references Derived calculations Experimental preparation Other Database references Experimental preparation Structure summary Other 1 0 2009-11-10 1 1 2011-07-13 1 2 2020-02-26 1 3 2021-08-18 1 4 2023-06-14 _pdbx_database_status.status_code_cs _pdbx_nmr_representative.selection_criteria _pdbx_nmr_spectrometer.model _struct_ref_seq_dif.details _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct.pdbx_model_details _pdbx_database_status.status_code_nmr_data Y BMRB Y RCSB 2009-10-21 REL REL REL REL THE STRUCTURE WAS DETERMINED USING TRIPLE RESONANCE SPECTROSCOPY. DATA FOR THE BACKBONE ASSIGNMENTS WAS ACQUIRED USING GFT NMR EXPERIMENTS. AUTOMATED RESONANCE ASSIGNMENTS WERE MADE USING AUTOASSIGN AND PATTERN-PICKER ALGORITHMS DEVELOPED FOR AUTOMATED ASSIGNMENTS OF GFT DATA. SIDE CHAIN ASSIGNMENTS WERE COMPLETED MANUALLY. AUTOMATED NOESY ASSIGNMENTS WERE MADE USING AUTOSTRUCTURE AND STRUCTURE SOLUTION WAS DETERMINED USING CYANA-2.1. 100 STRUCTURES WERE CALCULATED AND 20 BEST CONFORMERS WERE THEN REFINED IN A SHELL OF WATER USING CNS. INITIAL DIHEDRAL ANGLE CONSTRIANTS WERE OBTAINED FROM TALOS. COMPLETENESS OF THE ASSIGNMENTS INCLUDING THE N-TERMINAL 6XHIS TAG WERE BACKBONE:99% SIDECHAIN: 96%. THE ASSIGNMENTS WERE VALIDATED USING AVS SOFTWARE. structures with the lowest energy 100 20 0.0 2D 1H-15N HSQC 2D 1H-13C HSQC 3D HNCACB 3D CBCA(CO)NH 3D HBHA(CO)NH 3D HNCO 3D HNHA 3D HCCH-TOCSY 3D 1H-15N NOESY 3D 1H-13C NOESY 2D HNOE 1.129 mM [U-100% 13C; U-100% 15N] 20mM NH4OAc, 5mM CACL2, 200mM NACL 4.5 AMBIENT 298 K FINAL STRUCTURE QUALITY FACTORS DETERMINED USING PSVS SOFTWARE: ORDERED RESIDUES ARE DEFINED AS:15A-32A,34A-37A,42A-47A,53A-72A,75A-79A,85A-91A,101A-106A, 110A-116A.(A) RMSD(ORDERED RESIDUES):BACKBONE ATOMS: 0.7A; ALL ATOMS: 1.0A.(B) RAMACHANDRAN STATISTICS FOR ALL ORDERED RESIDUES: MOST FAVOURED REGIONS: 83.1% ADDITIONALLY ALLOWED REGIONS:16.9% (C) PROCHECK SCORES FOR ALL ORDERED RESIDUES (RAW/Z): PHI-PSI -0.76/-2.68, ALL: -0.42/-2.48 (D) MOLPROBITY CLASH SCORE (RAW/Z): 20.38/-1.97. (E) RPF SCORES FOR GOODNESS OF FIT TO NOESY DATA: RECALL:0.962 PRECISION: 0.919 F-MEASURE: 0.94 DP-SCORE 0.794. simulated annealing 1 lowest energy 1.129 MM [U-100% 13C; U-100% 15N] LAMIN-B1 PROTEIN, 90% H2O/10% D2O 1 90% H2O/10% D2O solution BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ refinement CNS 2.0.6 Zimmerman, Moseley, Kulikowski and Montelione chemical shift assignment AutoAssign 2.1 Moseley and Montelione chemical shift assignment AVS Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax processing NMRPipe 2008 Goddard peak picking Sparky 2.3 Huang, Tejero, Powers and Montelione structure solution AutoStructure 2.2.1 Guntert, Mumenthaler and Wuthrich geometry optimization CYANA 2.1 Bruker Biospin collection TopSpin 2.1 Varian collection VnmrJ 2.1 Goddard data analysis Sparky 2.3 Guntert, Mumenthaler and Wuthrich structure calculation CYANA 2.1 600 Varian INOVA 800 Bruker AVANCE MET 1 n 1 MET 1 A GLY 2 n 2 GLY 2 A HIS 3 n 3 HIS 3 A HIS 4 n 4 HIS 4 A HIS 5 n 5 HIS 5 A HIS 6 n 6 HIS 6 A HIS 7 n 7 HIS 7 A HIS 8 n 8 HIS 8 A SER 9 n 9 SER 9 A HIS 10 n 10 HIS 10 A MET 11 n 11 MET 11 A THR 12 n 12 THR 12 A GLY 13 n 13 GLY 13 A ASN 14 n 14 ASN 14 A VAL 15 n 15 VAL 15 A CYS 16 n 16 CYS 16 A ILE 17 n 17 ILE 17 A GLU 18 n 18 GLU 18 A GLU 19 n 19 GLU 19 A ILE 20 n 20 ILE 20 A ASP 21 n 21 ASP 21 A VAL 22 n 22 VAL 22 A ASP 23 n 23 ASP 23 A GLY 24 n 24 GLY 24 A LYS 25 n 25 LYS 25 A PHE 26 n 26 PHE 26 A ILE 27 n 27 ILE 27 A ARG 28 n 28 ARG 28 A LEU 29 n 29 LEU 29 A LYS 30 n 30 LYS 30 A ASN 31 n 31 ASN 31 A THR 32 n 32 THR 32 A SER 33 n 33 SER 33 A GLU 34 n 34 GLU 34 A GLN 35 n 35 GLN 35 A ASP 36 n 36 ASP 36 A GLN 37 n 37 GLN 37 A PRO 38 n 38 PRO 38 A MET 39 n 39 MET 39 A GLY 40 n 40 GLY 40 A GLY 41 n 41 GLY 41 A TRP 42 n 42 TRP 42 A GLU 43 n 43 GLU 43 A MET 44 n 44 MET 44 A ILE 45 n 45 ILE 45 A ARG 46 n 46 ARG 46 A LYS 47 n 47 LYS 47 A ILE 48 n 48 ILE 48 A GLY 49 n 49 GLY 49 A ASP 50 n 50 ASP 50 A THR 51 n 51 THR 51 A SER 52 n 52 SER 52 A VAL 53 n 53 VAL 53 A SER 54 n 54 SER 54 A TYR 55 n 55 TYR 55 A LYS 56 n 56 LYS 56 A TYR 57 n 57 TYR 57 A THR 58 n 58 THR 58 A SER 59 n 59 SER 59 A ARG 60 n 60 ARG 60 A TYR 61 n 61 TYR 61 A VAL 62 n 62 VAL 62 A LEU 63 n 63 LEU 63 A LYS 64 n 64 LYS 64 A ALA 65 n 65 ALA 65 A GLY 66 n 66 GLY 66 A GLN 67 n 67 GLN 67 A THR 68 n 68 THR 68 A VAL 69 n 69 VAL 69 A THR 70 n 70 THR 70 A ILE 71 n 71 ILE 71 A TRP 72 n 72 TRP 72 A ALA 73 n 73 ALA 73 A ALA 74 n 74 ALA 74 A ASN 75 n 75 ASN 75 A ALA 76 n 76 ALA 76 A GLY 77 n 77 GLY 77 A VAL 78 n 78 VAL 78 A THR 79 n 79 THR 79 A ALA 80 n 80 ALA 80 A SER 81 n 81 SER 81 A PRO 82 n 82 PRO 82 A PRO 83 n 83 PRO 83 A THR 84 n 84 THR 84 A ASP 85 n 85 ASP 85 A LEU 86 n 86 LEU 86 A ILE 87 n 87 ILE 87 A TRP 88 n 88 TRP 88 A LYS 89 n 89 LYS 89 A ASN 90 n 90 ASN 90 A GLN 91 n 91 GLN 91 A ASN 92 n 92 ASN 92 A SER 93 n 93 SER 93 A TRP 94 n 94 TRP 94 A GLY 95 n 95 GLY 95 A THR 96 n 96 THR 96 A GLY 97 n 97 GLY 97 A GLU 98 n 98 GLU 98 A ASP 99 n 99 ASP 99 A VAL 100 n 100 VAL 100 A LYS 101 n 101 LYS 101 A VAL 102 n 102 VAL 102 A ILE 103 n 103 ILE 103 A LEU 104 n 104 LEU 104 A LYS 105 n 105 LYS 105 A ASN 106 n 106 ASN 106 A SER 107 n 107 SER 107 A GLN 108 n 108 GLN 108 A GLY 109 n 109 GLY 109 A GLU 110 n 110 GLU 110 A GLU 111 n 111 GLU 111 A VAL 112 n 112 VAL 112 A ALA 113 n 113 ALA 113 A GLN 114 n 114 GLN 114 A ARG 115 n 115 ARG 115 A SER 116 n 116 SER 116 A THR 117 n 117 THR 117 A VAL 118 n 118 VAL 118 A PHE 119 n 119 PHE 119 A LYS 120 n 120 LYS 120 A THR 121 n 121 THR 121 A THR 122 n 122 THR 122 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N CYS 16 A N CYS 16 A O LYS 30 A O LYS 30 A N ILE 27 A N ILE 27 A O ILE 71 A O ILE 71 A N THR 70 A N THR 70 A O LEU 86 A O LEU 86 A N GLN 37 A N GLN 37 A O LEU 63 A O LEU 63 A O TYR 55 A O TYR 55 A N MET 44 A N MET 44 A N LYS 47 A N LYS 47 A O LYS 101 A O LYS 101 A N VAL 102 A N VAL 102 A O ARG 115 A O ARG 115 12 A A HH11 HZ3 ARG TRP 46 88 1.35 1 A A PRO PRO 82 83 38.83 7 A A PRO PRO 82 83 36.16 9 A A PRO PRO 82 83 38.02 17 A A PRO PRO 82 83 44.60 1 A HIS 4 -171.11 148.50 1 A HIS 7 -166.43 116.88 1 A THR 32 -109.36 40.84 1 A ILE 48 -164.51 -53.80 1 A ASP 50 69.07 -69.24 1 A ALA 74 60.66 -73.37 1 A ALA 76 -133.03 -39.94 1 A SER 81 67.25 71.45 1 A PRO 83 13.41 60.79 1 A THR 84 153.68 -52.93 1 A TRP 88 -69.14 91.04 1 A THR 96 -79.83 28.34 1 A ASP 99 -52.63 101.63 1 A PHE 119 -64.19 91.65 2 A HIS 8 -57.52 90.68 2 A SER 9 -126.72 -169.68 2 A ASN 14 -68.16 81.00 2 A ILE 48 -150.22 21.48 2 A SER 52 -145.37 33.03 2 A ASN 75 -93.71 43.18 2 A ASP 99 -67.92 89.18 3 A SER 81 59.83 81.36 3 A THR 84 -171.02 -38.20 3 A THR 96 176.46 -27.27 3 A ASP 99 -64.52 99.32 3 A ALA 113 -176.67 133.70 4 A ASN 14 -76.84 47.69 4 A GLU 18 -90.56 -69.25 4 A LYS 30 -162.66 119.90 4 A ILE 48 -135.99 -41.43 4 A ASP 50 72.47 -36.51 4 A THR 84 -154.96 -56.36 4 A THR 96 -157.35 26.25 5 A THR 12 -91.38 32.19 5 A PRO 38 -74.80 29.90 5 A MET 39 64.94 -71.18 5 A ASP 50 76.46 -58.75 5 A PRO 82 -48.79 170.84 5 A PRO 83 -16.82 -80.51 5 A THR 84 -78.62 -83.63 5 A TRP 88 -69.46 77.90 5 A LYS 89 -75.88 27.82 6 A HIS 3 -144.66 39.70 6 A HIS 7 -66.00 99.43 6 A MET 11 61.58 108.88 6 A THR 12 -94.26 36.51 6 A MET 39 -52.45 -72.26 6 A TYR 55 -160.47 114.21 6 A SER 59 -85.89 33.93 6 A VAL 69 -57.96 106.66 6 A THR 79 -51.10 104.92 6 A PRO 82 -55.91 178.60 6 A THR 84 176.71 -170.94 6 A ASP 85 -57.40 108.10 6 A LEU 86 -51.44 109.22 6 A THR 96 -130.56 -39.09 6 A ASN 106 -114.80 -167.40 6 A PHE 119 28.56 75.98 7 A HIS 6 -65.27 93.71 7 A LYS 25 -95.57 -63.39 7 A MET 39 -79.12 -71.01 7 A ILE 48 -171.20 -35.70 7 A SER 59 -73.41 23.72 7 A ALA 74 61.30 -69.18 7 A ASN 75 -72.86 36.17 7 A THR 79 -67.84 94.02 7 A ALA 80 51.64 -86.11 7 A SER 81 -170.46 110.52 7 A PRO 82 -46.21 160.61 7 A PRO 83 9.03 64.50 7 A THR 84 147.78 -67.59 7 A THR 96 -167.52 -63.25 7 A THR 121 66.40 98.37 8 A GLU 34 -85.73 43.12 8 A TYR 55 -163.57 117.99 8 A ALA 80 -89.87 42.41 8 A PRO 82 -44.12 163.84 8 A PRO 83 -11.02 -80.75 8 A THR 84 -106.37 -79.39 8 A TRP 88 -64.91 77.96 8 A VAL 100 30.73 88.57 8 A ARG 115 -175.60 147.71 8 A THR 121 57.85 102.33 9 A MET 39 64.17 -73.27 9 A ALA 74 56.51 -72.82 9 A ALA 76 -154.47 9.02 9 A SER 81 65.17 104.17 9 A PRO 82 -45.96 169.43 9 A PRO 83 10.76 65.45 9 A THR 84 144.74 -59.65 9 A ASP 85 -110.76 -168.62 9 A ASP 99 -57.91 89.86 9 A THR 117 -61.71 94.79 9 A VAL 118 -68.37 86.79 9 A PHE 119 -78.38 26.00 10 A HIS 10 -151.44 83.17 10 A GLU 19 173.82 152.51 10 A MET 39 -66.28 -85.59 10 A ILE 48 -169.74 -60.28 10 A ASP 50 67.45 -75.75 10 A ASN 75 -93.49 35.52 10 A SER 93 -179.09 -178.44 10 A TRP 94 -142.22 -82.64 10 A SER 107 47.71 -77.52 10 A VAL 112 -98.91 -68.07 11 A SER 9 -178.30 112.36 11 A GLU 18 -81.54 -77.02 11 A PRO 38 -73.46 21.31 11 A MET 39 63.50 -78.84 11 A ASP 50 73.68 -56.25 11 A ARG 60 -140.37 17.68 11 A ASN 75 -91.08 41.57 11 A PRO 82 -54.33 -178.34 11 A THR 84 -158.13 -60.68 11 A ASP 85 -122.10 -168.87 11 A ASN 92 -109.83 -169.52 11 A SER 107 59.92 -77.52 11 A GLN 108 -80.93 -71.91 12 A HIS 4 -66.75 91.78 12 A THR 12 -73.90 -74.35 12 A PRO 38 -77.95 48.07 12 A MET 39 67.23 -69.40 12 A ILE 48 -166.10 -46.48 12 A ALA 65 -59.76 107.24 12 A SER 81 59.96 94.54 12 A THR 84 -163.80 -48.28 12 A SER 93 -67.41 -173.01 12 A SER 107 -74.45 28.96 13 A HIS 4 -172.72 107.32 13 A ASP 23 -121.28 -53.08 13 A ASP 36 -52.16 104.71 13 A ILE 48 -167.78 -40.63 13 A SER 52 -163.07 101.51 13 A ALA 80 -62.25 79.78 13 A SER 81 66.08 89.87 13 A THR 84 177.01 -44.78 13 A GLU 98 66.41 163.13 13 A PHE 119 -61.35 98.15 14 A HIS 6 60.64 85.56 14 A THR 84 -174.72 -47.17 14 A TRP 88 -66.96 93.46 14 A SER 93 -175.21 -179.09 14 A GLN 114 -155.65 46.88 14 A LYS 120 -143.90 27.12 15 A PRO 38 -58.23 107.74 15 A ASP 50 -136.94 -43.78 15 A PRO 83 0.29 103.57 15 A THR 84 51.28 -67.19 15 A ASP 85 -68.21 -178.47 15 A ASN 92 -100.64 -137.16 15 A TRP 94 45.39 22.24 15 A ASP 99 -78.39 43.97 15 A THR 121 -140.22 31.82 16 A ILE 48 -159.17 -42.58 16 A SER 59 -86.46 34.62 16 A THR 96 76.73 -32.86 16 A ASP 99 59.12 73.29 17 A THR 12 -96.45 -157.88 17 A ASP 23 -81.54 -70.37 17 A ASP 36 -64.66 91.03 17 A ASP 50 -149.75 -15.33 17 A ALA 74 64.83 -67.14 17 A ALA 80 -67.69 91.05 17 A SER 81 72.84 87.09 17 A PRO 82 -50.67 -176.17 17 A PRO 83 14.82 47.92 17 A THR 84 157.67 -53.36 17 A SER 107 -67.94 8.37 17 A VAL 112 -122.44 -64.16 17 A VAL 118 -62.29 96.25 18 A HIS 6 -101.86 -78.78 18 A GLU 19 178.52 160.46 18 A ASP 50 70.18 -4.29 18 A ASN 75 -97.07 32.48 18 A ALA 80 -69.91 2.65 18 A SER 81 -169.68 86.04 18 A TRP 88 -69.60 79.35 18 A THR 96 -170.95 -42.69 18 A PHE 119 -59.71 95.59 19 A ALA 74 47.47 -82.57 19 A ASN 75 -77.46 36.24 19 A ALA 80 -83.00 39.01 19 A PRO 82 -44.50 -164.08 19 A THR 84 -67.15 -71.63 19 A SER 93 66.60 139.28 19 A THR 96 -151.68 -50.17 19 A PHE 119 -79.17 21.78 19 A LYS 120 -58.02 98.74 20 A LYS 25 -129.81 -57.49 20 A PRO 38 -75.94 46.51 20 A MET 39 63.11 -79.94 20 A THR 84 -139.08 -66.00 20 A ASN 92 -75.24 -164.22 20 A VAL 112 -125.08 -60.83 20 A THR 117 -68.45 -94.37 20 A VAL 118 176.47 130.33 20 A THR 121 -63.46 0.09 NMR solution structure of Lamin-B1 protein from Homo sapiens: Northeast Structural Genomics Consortium MEGA target, HR5546A (439-549) 1 N N STRUCTURAL PROTEIN PSI-2, NESG, HR5546A, Lamin-B1, GFT, Acetylation, Chromosomal rearrangement, Coiled coil, Intermediate filament, Leukodystrophy, Lipoprotein, Membrane, Nucleus, Phosphoprotein, Polymorphism, Prenylation, Structural Genomics, Protein Structure Initiative, Northeast Structural Genomics Consortium, STRUCTURAL PROTEIN A PRO 82 A PRO 82 2 A PRO 83 A PRO 83 -0.92 A PRO 82 A PRO 82 3 A PRO 83 A PRO 83 -1.74 A PRO 82 A PRO 82 4 A PRO 83 A PRO 83 -0.52 A PRO 82 A PRO 82 5 A PRO 83 A PRO 83 11.18 A PRO 82 A PRO 82 6 A PRO 83 A PRO 83 6.27 A PRO 82 A PRO 82 8 A PRO 83 A PRO 83 17.11 A PRO 82 A PRO 82 10 A PRO 83 A PRO 83 3.06 A PRO 82 A PRO 82 11 A PRO 83 A PRO 83 5.27 A PRO 82 A PRO 82 12 A PRO 83 A PRO 83 -1.15 A PRO 82 A PRO 82 13 A PRO 83 A PRO 83 6.39 A PRO 82 A PRO 82 14 A PRO 83 A PRO 83 -1.62 A PRO 82 A PRO 82 15 A PRO 83 A PRO 83 25.21 A PRO 82 A PRO 82 16 A PRO 83 A PRO 83 1.44 A PRO 82 A PRO 82 18 A PRO 83 A PRO 83 2.10 A PRO 82 A PRO 82 19 A PRO 83 A PRO 83 11.03 A PRO 82 A PRO 82 20 A PRO 83 A PRO 83 -2.98 LMNB1_HUMAN UNP 1 439 P20700 TGNVCIEEIDVDGKFIRLKNTSEQDQPMGGWEMIRKIGDTSVSYKYTSRYVLKAGQTVTIWAANAGVTASPPTDLIWKNQ NSWGTGEDVKVILKNSQGEEVAQRSTVFKTT 439 549 2KPW 12 122 P20700 A 1 12 122 1 expression tag MET 1 2KPW A P20700 UNP 1 1 expression tag GLY 2 2KPW A P20700 UNP 2 1 expression tag HIS 3 2KPW A P20700 UNP 3 1 expression tag HIS 4 2KPW A P20700 UNP 4 1 expression tag HIS 5 2KPW A P20700 UNP 5 1 expression tag HIS 6 2KPW A P20700 UNP 6 1 expression tag HIS 7 2KPW A P20700 UNP 7 1 expression tag HIS 8 2KPW A P20700 UNP 8 1 expression tag SER 9 2KPW A P20700 UNP 9 1 expression tag HIS 10 2KPW A P20700 UNP 10 1 expression tag MET 11 2KPW A P20700 UNP 11 4 2 4 anti-parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel A VAL 15 A VAL 15 A ILE 20 A ILE 20 A PHE 26 A PHE 26 A ASN 31 A ASN 31 A GLN 67 A GLN 67 A TRP 72 A TRP 72 A LEU 86 A LEU 86 A ILE 87 A ILE 87 A GLN 37 A GLN 37 A PRO 38 A PRO 38 A VAL 62 A VAL 62 A LEU 63 A LEU 63 A SER 52 A SER 52 A LYS 56 A LYS 56 A GLU 43 A GLU 43 A LYS 47 A LYS 47 A LYS 101 A LYS 101 A LYS 105 A LYS 105 A GLU 111 A GLU 111 A SER 116 A SER 116 1 P 1